Rosmantuzumab: A Deep Dive into OMP-131R10 Rosmantuzumab, originally known by OMP-131R10, represents a unique monoclonal antibody engineered to inhibit granulocyte-macrophage colony-stimulating GM-CSF. Its mode of action requires selectively attaching to GM-CSF, inhibiting its interaction upon its receptor on cells. Clinical research have explored